Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

Amit Oza, Adrian D Cook, Jacobus Pfisterer, Andrew Embleton, Jonathan A. Ledermann, Eric Pujade-lauraine, Gunnar Kristensen, Mark S Carey, Philip Beale, Andrés Cervantes, Tjoung-Won Park-Simon, Gordon Js Rustin, F Joly, Mansoor R. Mirza, Marie Plante, Michael Quinn, Andres Poveda, Gordon C Jayson, Dan Stark, Ann Marie SwartLaura Farrelly, Richard S Kaplan, Mahesh K.b. Parmar, Timothy J. Perren

Research output: Contribution to journalArticle

408 Citations (Scopus)
6 Downloads (Pure)
Original languageEnglish
Pages (from-to)928–936
Number of pages9
JournalThe Lancet Oncology
Volume16
Issue number8
Early online date24 Jun 2015
DOIs
Publication statusPublished - Aug 2015

Cite this